Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Evaluable Disease

Known as: Evaluable 
Disease that cannot be measured directly by the size of the tumor but can be evaluated by other methods specific to a particular clinical trial.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Purpose The prevalence and features of treatment-emergent small-cell neuroendocrine prostate cancer (t-SCNC) are not well… Expand
Is this relevant?
Review
2018
Review
2018
Purpose Genetic alterations causing overexpression of programmed death-1 ligands are near universal in classic Hodgkin lymphoma… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 2
Is this relevant?
Review
2018
Review
2018
CONTEXT Since 2012 uniformed reporting of complications after urological procedures has been advocated by the European… Expand
  • table 1
  • table 2
Is this relevant?
Review
2018
Review
2018
Purpose The anti-programmed death-1 antibody pembrolizumab was evaluated in KEYNOTE-028, a multicohort, phase IB study of… Expand
  • table 2
  • table 1
  • table 3
  • figure 1
  • figure 2
Is this relevant?
Review
2018
Review
2018
BACKGROUND Immune checkpoint inhibitors are a new standard of care for patients with advanced non-small-cell lung cancer (NSCLC… Expand
Is this relevant?
Review
2017
Review
2017
BACKGROUND Colorectal cancers (CRCs) expressing programmed death ligand 1 (PD-L1) have poor prognosis. In the multicohort KEYNOTE… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Review
2017
Review
2017
STUDY QUESTION How effective is ovarian tissue cryopreservation (OTC)? SUMMARY ANSWER In our cohort of patients who underwent… Expand
  • table I
  • figure 1
  • table II
Is this relevant?
Review
2017
Review
2017
Purpose: Treatment options for unresectable paraganglioma (PGL)/pheochromocytoma (PCC), especially with uncontrolled secondary… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2000
Highly Cited
2000
BACKGROUND Irinotecan is active against colorectal cancer in patients whose disease is refractory to fluorouracil. We… Expand
Is this relevant?
Highly Cited
1974
Highly Cited
1974
Sixty-one evaluable patients, 19 with advanced aplastic anemia and 42 with end stage hematological malignancies, were conditioned… Expand
Is this relevant?